Eagle Asset Management Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$21.2 - $31.03 $1.2 Million - $1.75 Million	56,386 Added 11.33%	553,860 $16.9 Million
Q3 2023 Nov 13, 2023	BUY	$26.2 - $36.08 $379,873 - $523,123	14,499 Added 3.0%	497,474 $13.4 Million
Q2 2023 Aug 09, 2023	BUY	$25.16 - $41.38 $1.68 Million - $2.77 Million	66,970 Added 16.1%	482,975 $17.2 Million
Q1 2023 May 08, 2023	SELL	$23.68 - $38.51 $923,259 - $1.5 Million	-38,989 Reduced 8.57%	416,005 $10.6 Million
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $7,756 - $11,235	277 Added 0.06%	454,994 $18.5 Million
Q3 2022 Nov 07, 2022	SELL	$29.63 - $48.31 $1.5 Million - $2.45 Million	-50,716 Reduced 10.03%	454,717 $15 Million
Q2 2022 Aug 10, 2022	SELL	$27.79 - $50.61 $837,951 - $1.53 Million	-30,153 Reduced 5.63%	505,433 $17.8 Million
Q1 2022 May 12, 2022	BUY	$39.62 - $69.97 $861,655 - $1.52 Million	21,748 Added 4.23%	535,586 $24.6 Million
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $171,423 - $243,487	-2,951 Reduced 0.57%	513,838 $34.6 Million
Q3 2021 Nov 10, 2021	SELL	$58.38 - $84.96 $3.62 Million - $5.27 Million	-61,981 Reduced 10.71%	516,789 $32.3 Million
Q2 2021 Aug 11, 2021	SELL	$62.15 - $90.32 $1.13 Million - $1.64 Million	-18,148 Reduced 3.04%	578,770 $47.9 Million
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $4.61 Million - $6.8 Million	-75,186 Reduced 11.19%	596,918 $40 Million
Q4 2020 Feb 12, 2021	SELL	$43.82 - $85.37 $3.31 Million - $6.45 Million	-75,519 Reduced 10.1%	672,104 $51.6 Million
Q3 2020 Nov 12, 2020	BUY	$33.21 - $51.27 $1.31 Million - $2.02 Million	39,486 Added 5.58%	747,623 $32.5 Million
Q2 2020 Aug 12, 2020	BUY	$26.12 - $43.27 $7,052 - $11,682	270 Added 0.04%	708,137 $30.2 Million
Q1 2020 May 11, 2020	BUY	$20.56 - $63.12 $78,189 - $240,045	3,803 Added 0.54%	707,867 $20.4 Million
Q4 2019 Feb 07, 2020	BUY	$28.14 - $73.01 $19.8 Million - $51.4 Million	704,064 New	704,064 $44.7 Million

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account